BEAT— "A heartbeat ahead"

The problem has been identified. The technology exists. What’s missing is the architecture that transforms health data into timely medical decisions, anywhere in the world. BEAT is that architecture

BIOMETRIC EVALUATION AND ACCESIBLE TELEMEDICINE

Our Strategic Partners

Technical and Scientific Validation:
Partnership with EIA University

Unlike a project seeking funding for an idea, BEAT already has a formalized technical implementation partner. EIA University (Antioquia, Colombia) is co-developing the hardware and software for the “Wearable” device—Component 2 of the BEAT model—under a current Master Project Proposal, a Letter of Understanding, and a Strategic Alliance document

Structuring the Ready-to-Execute Operating Model:
KEATON

KEATON International Consulting Group, designs the “Turnkey | Shovel-Ready” Bankable Project so that the BEAT Initiative’s operational model can be implemented at any time, in any country, region, or healthcare system, in a standardized and scalable manner, ensuring sustainable impact and efficient use of the valuable resources provided through cooperation and funding for the BEAT Initiative—under a valid Framework Agreement, a Letter of Understanding, and a Strategic Alliance document

The promise of a healthcare model that anticipates illness rather than reacting to it

The Scientific Origin: The Perspective of DR. JOHNNY ALDER IZQUIERDO
ERGOSPORT

BEAT emerged from the real-world clinical practice of Dr. Johnny Alder Izquierdo, a cardiologist and specialist in internal medicine, through his organization ERGOSPORT His clinical work on the autonomic nervous system (ANS)—the great silent regulator of the stress response and, by extension, of a large portion of noncommunicable diseases (NCDs)—allowed him to identify something that the wearables industry had not yet fully grasped: health sensors already capture the biometric indicators necessary for a comprehensive diagnosis, but no one is integrating them for a real clinical purpose. This medical—not technological—interpretation of the problem is BEAT’s foundational intellectual asset: it transforms a generic monitoring device into an architecture for timely clinical decision-making. It is this clinical vision, validated by years of practice and evidence with patients, that today translates into the intellectual property of the diagnostic model and the initiative’s Medical-Scientific Directorate